Volume 28, Issue 3 e14759
CASE REPORT

Identification of Irpex and Rhodotorula on surveillance bronchoscopy in a pediatric lung transplant recipient: A case report and review of literature of these atypical fungal organisms

Daniel T. Atwood

Daniel T. Atwood

Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA

Search for more papers by this author
Julia R. Köhler

Julia R. Köhler

Division of Infectious Disease, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA

Search for more papers by this author
Sara O. Vargas

Sara O. Vargas

Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA

Search for more papers by this author
Wai Wong

Wai Wong

Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA

Search for more papers by this author
Timothy Klouda

Corresponding Author

Timothy Klouda

Division of Pulmonary Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA

Correspondence

Timothy Klouda, Division of Pulmonary Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA.

Email: [email protected]

Search for more papers by this author
First published: 16 April 2024

Primary Investigator/Senior Author: Timothy Klouda.

Abstract

Background

Invasive fungal disease (IFD) is a frequent complication in pediatric lung transplant recipients, occurring in up to 12% of patients in the first year. Risk factors for infection include impaired lung defenses and intense immunosuppressive regimens. While most IFD occurs from Aspergillus, other fungal conidia are continuously inhaled, and infections with fungi on a spectrum of human pathogenicity can occur.

Case Report

We report a case of a 17-year-old lung transplant recipient in whom Irpex lacteus and Rhodotorula species were identified during surveillance bronchoscopy. She was asymptomatic and deemed to be colonized by Irpex lacteus and Rhodotorula species following transplant. 2 years after transplantation, she developed a fever, respiratory symptoms, abnormal lung imaging, and histological evidence of acute and chronic bronchitis on transbronchial biopsy. After developing symptoms concerning for a pulmonary infection and graft dysfunction, she was treated for a presumed IFD. Unfortunately, further diagnostic testing could not be performed at this time given her tenuous clinical status. Despite the initiation of antifungal therapy, her graft function continued to decline resulting in a second lung transplantation.

Conclusions

This case raises the concern for IFD in lung transplant recipients from Irpex species. Further investigation is needed to understand the pathogenicity of this organism, reduce the incidence and mortality of IFD in lung transplant recipients, and refine the approach to diagnosis and manage the colonization and isolation of rare, atypical fungal pathogens in immunocompromised hosts.

CONFLICT OF INTEREST STATEMENT

None.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.